Mats Wahlstrom - Aug 10, 2023 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director, 10%+ Owner
Signature
/s/ Sean Murphy, Attorney-in-Fact for Mats Wahlstrom
Stock symbol
TLSI
Transactions as of
Aug 10, 2023
Transactions value $
$0
Form type
4
Date filed
8/14/2023, 06:19 PM
Previous filing
Jun 9, 2023
Next filing
Feb 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Stock Option (right to buy) Award $0 +35K $0.00 35K Aug 10, 2023 Common Stock 35K $11.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.